MAXCYTE INC. - COMMON
3.3800
26-نوفمبر-24 16:45:00
15 متأخرة بدقائق
الأسهم
-0.2300
-6.37%
نطاق اليوم
3.3300 - 3.6100
ISIN
N/A
المصدر
NASDAQ
-
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
08 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
03 يناير 2024 08:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
02 يناير 2024 02:00:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 ديسمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
16 نوفمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
08 نوفمبر 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Participate in Two Upcoming Investor Conferences
06 نوفمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
04 أكتوبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
06 سبتمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Participate in Baird Global Healthcare Conference
05 سبتمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
09 أغسطس 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
01 أغسطس 2023 08:05:51 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023
13 يوليو 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
10 يوليو 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
06 يوليو 2023 08:05:05 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
01 يونيو 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance
10 مايو 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
04 مايو 2023 08:05:53 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023
12 أبريل 2023 16:05:30 بحسب Nasdaq GlobeNewswire
-
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
27 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire